Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Buchta, C; Springer, D; Jovanovic, J; Borsodi, C; Weidner, L; Sareban, N; Radler, U; Muller, MM; Griesmacher, A; Puchhammer-Stockl, E; Wagner, T; Jungbauer, C; Stiasny, K; Weseslindtner, L.
Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stage
CLIN CHEM LAB MED. 2023; Doi: 10.1515/cclm-2022-1161
Web of Science PubMed FullText FullText_MUG


Co-Autor*innen der Med Uni Graz
Sareban Nazanin
Wagner Thomas

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Objectives: The WHO's standardized measuring unit, "binding antibody units per milliliter (BAU/mL), " should allow the harmonization of quantitative results by different commercial Anti-SARS-CoV-2 immunoassays. However, multiple studies demonstrate inter-assay discrepancies. The antigenic changes of the Omicron variant affect the performance of Spike-specific immunoassays. This study evaluated the variation of quantitative Anti-SARS-CoV-2-Spike antibody measurements among 46, 50, and 44 laboratories in three rounds of a national external quality assessment (EQA) prior to and after the emergence of the Omicron variant in a diagnostic near-to-real-life setting.Methods: We analyzed results reported by the EQA participant laboratories from single and sequential samples from SARS-CoV-2 convalescent, acutely infected, and vaccinated individuals, including samples obtained after primary and breakthrough infections with the Omicron variant.Results: The three immunoassays most commonly used by the participants displayed a low intra-assay and inter-laboratory variation with excellent reproducibility using identical samples sent to the participants in duplicates. In contrast, the inter-assay variation was very high with all samples. Notably, the ratios of BAU/mL levels quantified by different immunoassays were not equal among all samples but differed between vaccination, past, and acute infection, including primary infection with the Omicron variant. The antibody kinetics measured in vaccinated individuals strongly depended on the applied immunoassay.Conclusions: Measured BAU/mL levels are only inter-changeable among different laboratories when the same assay was used for their assessment. Highly variable ratios of BAU/mL quantifications among different immunoassays and infection stages argue against the usage of universal inter-assay conversion factors.

Find related publications in this database (Keywords)
© Med Uni Graz Impressum